Clinical case of oropharyngeal metastasis of kidney cancer

by Т. А. Aketova, R. I. Azizyan, S. D. Bezhanova, А. А. Zotova, V. Zh. Brzhezovskiy
Published 2018-07-01

Laryngeal paraganglioma: clinical case presentation

by R. A. Khasanov, R. I. Azizyan, G. V. Ungiadze, S. D. Bezhanova, A. I. Pavlovskaya
Published 2016-10-01

Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

by E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii
Published 2021-02-01

Matrix metalloproteinases 2, 7, 8, 9 and their type 1 tissue inhibitor in serum of renal cancer patients: clinical and pathologic correlations

by E. S. Gershtein, V. V. Mushtenko, E. A. Korotkova, S. D. Bezhanova, A. A. Morozov, A. A. Alferov, I. A. Kazantseva, N. E. Kushlinskii
Published 2017-05-01

Key VEGF signaling system components and matrix metalloproteinases in the diagnosis and prognosis of overall survival of patients with renal cell cancer

by N. E. Kushlinskii, E. S. Gershtein, A. V. Kolpakov, S. D. Bezhanova, V. V. Mushtenko, E. A. Korotkova, D. Yu. Pushkar, V. V. Bazaev
Published 2020-07-01

Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma

by D. G. Zaridze, N. N. Mazurenko, S. D. Bezhanova, D. M. Maksimovich, O. V. Shangina, V. A. Draudin-Krylenko, A. F. Mukeria, V. B. Matveev
Published 2019-04-01

Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations

by N. E. Kushlinskii, E. S. Gershtein, I. O. Goryatcheva, A. A. Morozov, A. A. Alferov, S. D. Bezhanova, I. A. Kazantseva, V. V. Bazaev, V. B. Matveev
Published 2019-04-01